Shares of Apollo Medical Holdings Inc (NASDAQ:AMEH) have received a consensus broker rating score of 2.00 (Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One analyst has rated the stock with a buy rating.

Analysts have set a one year consensus price target of $25.00 for the company and are forecasting that the company will post $0.08 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Apollo Medical an industry rank of 176 out of 255 based on the ratings given to related companies.

Several equities research analysts have weighed in on AMEH shares. ValuEngine upgraded shares of Apollo Medical from a “hold” rating to a “buy” rating in a report on Tuesday, January 29th. Zacks Investment Research lowered shares of Apollo Medical from a “buy” rating to a “hold” rating in a report on Wednesday, January 16th.

AMEH stock traded up $0.07 during midday trading on Friday, reaching $19.10. The company’s stock had a trading volume of 27,102 shares, compared to its average volume of 30,056. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.40 and a current ratio of 2.40. The stock has a market cap of $683.76 million, a PE ratio of 65.86, a PEG ratio of 5.62 and a beta of -1.17. Apollo Medical has a 52 week low of $13.01 and a 52 week high of $30.00.

Apollo Medical (NASDAQ:AMEH) last posted its earnings results on Monday, March 18th. The company reported ($0.08) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.12 by ($0.20). The firm had revenue of $105.46 million during the quarter. Apollo Medical had a return on equity of 6.00% and a net margin of 2.08%. As a group, sell-side analysts predict that Apollo Medical will post 0.34 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently bought and sold shares of AMEH. Vanguard Group Inc raised its holdings in Apollo Medical by 184.8% in the third quarter. Vanguard Group Inc now owns 928,911 shares of the company’s stock worth $20,501,000 after purchasing an additional 602,710 shares during the period. BlackRock Inc. raised its holdings in Apollo Medical by 8.7% in the fourth quarter. BlackRock Inc. now owns 353,218 shares of the company’s stock worth $7,012,000 after purchasing an additional 28,411 shares during the period. Northern Trust Corp raised its holdings in Apollo Medical by 33.2% in the fourth quarter. Northern Trust Corp now owns 111,883 shares of the company’s stock worth $2,221,000 after purchasing an additional 27,894 shares during the period. Bank of New York Mellon Corp raised its holdings in Apollo Medical by 63.4% in the fourth quarter. Bank of New York Mellon Corp now owns 59,862 shares of the company’s stock worth $1,188,000 after purchasing an additional 23,217 shares during the period. Finally, Geode Capital Management LLC raised its holdings in Apollo Medical by 14.3% in the fourth quarter. Geode Capital Management LLC now owns 183,445 shares of the company’s stock worth $3,641,000 after purchasing an additional 22,917 shares during the period. Institutional investors own 6.73% of the company’s stock.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc, an integrated health care delivery and management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Featured Article: Understanding debt-to-equity ratio in fundamental analysis

Get a free copy of the Zacks research report on Apollo Medical (AMEH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.